The internationalisation of innovation to China: The case of AstraZeneca PLC.

Shasha Zhao, Marina Papanastassiou, Hui Tan

Research output: Chapter in Book/Report/Conference proceedingChapter


The internationalisation of firms is increasingly concerned with locating innovation activities in the most appropriate locations, particularly for more strategic research and development projects. This article attempts to explore this area by taking a slightly different perspective – the internationalisation of innovations by advance-economy firms in less-advanced economies – which is increasingly prominent in international business development. This article describes the history of international expansion of AstraZeneca from 1990s to year 2014, which demonstrates the development of the company with its unique approach to international business operations, and in particular its innovation. In order to explain such a progress, considerations are given to a number of theoretical frameworks in terms of their explanatory power.
Original languageEnglish
Title of host publicationAcademy of International Business 42nd UKI Chapter Conference Proceedings. Manchester Metropolitan University Business School
ISBN (Electronic)978-1-910029-09-1
Publication statusPublished - 23 Jun 2015

Cite this